Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model (Q34449503)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model (English)

1 reference

Europe PubMed Central

2 August 2017

pathophysiology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Campylobacter jejuni

object named as

Campylobacter jejuni

1 reference

based on heuristic

inferred from title

1

object named as

Mark Pimentel

1 reference

Europe PubMed Central

2 August 2017

author name string

Walter Morales

2

1 reference

Europe PubMed Central

2 August 2017

Venkata Pokkunuri

3

1 reference

Europe PubMed Central

2 August 2017

Constantinos Brikos

4

1 reference

Europe PubMed Central

2 August 2017

Sun Moon Kim

5

1 reference

Europe PubMed Central

2 August 2017

Seong Eun Kim

6

1 reference

Europe PubMed Central

2 August 2017

Konstantinos Triantafyllou

7

1 reference

Europe PubMed Central

2 August 2017

Stacy Weitsman

8

1 reference

Europe PubMed Central

2 August 2017

Zachary Marsh

9

1 reference

Europe PubMed Central

2 August 2017

Emily Marsh

10

1 reference

Europe PubMed Central

2 August 2017

Kathleen S Chua

11

1 reference

Europe PubMed Central

2 August 2017

Shanthi Srinivasan

12

1 reference

Europe PubMed Central

2 August 2017

Gillian M Barlow

13

1 reference

Europe PubMed Central

2 August 2017

Christopher Chang

14

1 reference

Europe PubMed Central

2 August 2017

publication date

26 November 2014

1 reference

Europe PubMed Central

2 August 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

2 August 2017

60

1 reference

Europe PubMed Central

2 August 2017

1195-1205

1 reference

Europe PubMed Central

2 August 2017

5

1 reference

Europe PubMed Central

2 August 2017

https://scigraph.springernature.com/pub.10.1007/s10620-014-3435-5

0 references

Epidemiology of IBS.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

The effect of irritable bowel syndrome on health-related quality of life and health care expenditures

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Towards positive diagnosis of the irritable bowel

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

New clinical method for distinguishing D-IBS from other gastrointestinal conditions causing diarrhea: the LA/IBS diagnostic strategy

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Small intestinal bacterial overgrowth: what it is and what it is not.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Rifaximin therapy for patients with irritable bowel syndrome without constipation

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Postinfectious irritable bowel syndrome--a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

A new rat model links two contemporary theories in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Role of Cytolethal Distending Toxin in Altered Stool Form and Bowel Phenotypes in a Rat Model of Post-infectious Irritable Bowel Syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post infectious functional and microbial bowel changes

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Spontaneous electrical activity of interstitial cells of Cajal isolated from canine proximal colon

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Loss of CD117 (c-kit)- and CD34-positive ICC and associated CD34-positive fibroblasts defines a subpopulation of chronic intestinal pseudo-obstruction.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Estimating the contribution of acute gastroenteritis to the overall prevalence of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Anti-enteric neuronal antibodies and the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Vinculin regulates cell-surface E-cadherin expression by binding to beta-catenin

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

New insights into vinculin function and regulation

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Vinculin--a dynamic regulator of cell adhesion

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

The vinculin C-terminal hairpin mediates F-actin bundle formation, focal adhesion, and cell mechanical properties

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Heterozygous inactivation of the vinculin gene predisposes to stress-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Helicobacter pullorum cytolethal distending toxin targets vinculin and cortactin and triggers formation of lamellipodia in intestinal epithelial cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Shigella applies molecular mimicry to subvert vinculin and invade host cells

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

The Rickettsia Surface Cell Antigen 4 Applies Mimicry to Bind to and Activate Vinculin

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3435-5

21 January 2018

Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25424202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/25424202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25424202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin

1 reference

https://pubmed.ncbi.nlm.nih.gov/25424202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25424202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25424202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-014-3435-5

1 reference

Europe PubMed Central

2 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34449503&oldid=1968185560"